Skip to content
Tenfell
Awarded contract
Published 27 Apr 2023

NHS Framework Agreement for Branded medicines - National

NHS England · London

Key facts

Awarded
15 May 2022
Contract starts
30 Apr 2022
Contract ends
30 Apr 2024
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 50 suppliers

SupplierValue
FRESENIUS KABI LIMITED—
Baxter Healthcare Ltd—
Takeda UK Limited—
Colonis Pharma Ltd—
Crescent Pharma Limited—
CST Pharma Ltd—
Focus Pharmaceuticals Ltd—
GlaxoSmithKline—
Janssen-Cilag Ltd—
Martindale Pharma—
Pfizer Ltd—
Ranbaxy (UK) Ltd—
Teva UK Ltd—
Bayer plc—
Karo Healthcare Ltd—
Univar Solutions BV—
Abbvie Ltd—
Aguettant Ltd—
Aventis Pharma Ltd T/A Sanofi—
B. Braun Medical Limited—
Ennogen Healthcare Ltd—
Grunenthal Ltd—
Napp Pharmaceuticals—
Rosemont Pharmaceuticals Ltd—
Sandoz Ltd—
Selective Supplies Ltd—
Thornton & Ross Ltd—
Typharm Ltd—
Wockhardt UK Limited—
Accord-UK Ltd—
AstraZeneca—
Eli Lilly & Company Ltd—
Kent Pharma Ltd—
Merck Sharpe & Dohme (UK) Limited—
Mylan—
Neon Healthcare Ltd—
Novo Nordisk—
Organon Pharmaceuticals UK Ltd—
Roche Products Ltd—
Zentiva Pharma UK Ltd—
Day Lewis Medical Ltd—
Drugsrus Ltd—
Fontus Health Ltd—
Roma Pharmaceuticals Limited—
Thea Pharmaceuticals Limited—
Tillomed Laboratories ltd—
FLYNN PHARMA LTD—
Cipla Limited—
Glenmark Pharmaceuticals Europe Ltd—
Intrapharm Laboratories Ltd—

Description

NHS Framework Agreement for Branded medicines - National

FIND A TENDER (FTS) Reference number FTS-003607

Offer reference number CM/PHR/21/5643 NHS Framework Agreement for Branded Medicines - National

Period of Framework: 1 May 2022 to 30 April 2024

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.